CytoMed Therapeutics Ltd
GDTCNasdaqHealthcare · Pharmaceutical Preparations · U0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Choo Chee KongActivist (13D)Oct 29, 2025
- Mdr LtdPassive (13G)Mar 24, 2025
- 28 Consultants LtdPassive (13G)Mar 4, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 71,090 | 2.7 | +4.3% |
| Apr 30, 2026 | 68,135 | 11.2 | -5.3% |
| Apr 15, 2026 | 71,945 | 10.4 | -13.0% |
| Mar 31, 2026 | 82,681 | 10.0 | -29.4% |
| Mar 13, 2026 | 117,191 | 9.7 | -14.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.